Atea Pharmaceuticals Stock Alpha and Beta Analysis

AVIR -  USA Stock  

USD 31.57  3.12  10.97%

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Atea Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Atea Pharmaceuticals over a specified time horizon. Remember, high Atea Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Please continue to Atea Pharmaceuticals Backtesting, Atea Pharmaceuticals Valuation, Atea Pharmaceuticals Correlation, Atea Pharmaceuticals Hype Analysis, Atea Pharmaceuticals Volatility, Atea Pharmaceuticals History and analyze Atea Pharmaceuticals Performance.

Search Beta 

 
Refresh
Please note that although Atea Pharmaceuticals alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Atea Pharmaceuticals did 0.47  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Atea Pharmaceuticals stock's relative risk over its benchmark. Atea Pharmaceuticals has a beta of 1.12  . Let's try to break down what Atea Pharmaceuticals's beta means in this case. Atea Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Atea Pharmaceuticals is expected to follow.
Atea Pharmaceuticals Book Value per Share is relatively stable at the moment as compared to the past year. Atea Pharmaceuticals reported last year Book Value per Share of 25.37. As of 09/27/2021, Tangible Assets Book Value per Share is likely to grow to 43.16, while Enterprise Value over EBITDA is likely to drop (297.36) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Atea Pharmaceuticals Quarterly Book Value per Share

7.225Share

Atea Pharmaceuticals Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Atea Pharmaceuticals market risk premium is the additional return an investor will receive from holding Atea Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Atea Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Atea Pharmaceuticals' performance over market.
α0.47   β1.12
90 days against DJI

Atea Pharmaceuticals expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Atea Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Atea Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Atea Pharmaceuticals Market Price Analysis

Market price analysis indicators help investors to evaluate how Atea Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Atea Pharmaceuticals shares will generate the highest return on investment. By understating and applying Atea Pharmaceuticals stock market price indicators, traders can identify Atea Pharmaceuticals position entry and exit signals to maximize returns.

Atea Pharmaceuticals Return and Market Media

The median price of Atea Pharmaceuticals for the period between Tue, Jun 29, 2021 and Mon, Sep 27, 2021 is 27.13 with a coefficient of variation of 11.56. The daily time series for the period is distributed with a sample standard deviation of 3.1, arithmetic mean of 26.78, and mean deviation of 2.69. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
      Timeline 
1
EPS Estimate06/30/2021
2
COVID-19 drug developer Adagio plans IPO to cap fast rise - ...07/19/2021
3
Financial Statements07/23/2021
4
Atea Pharmaceuticals Inc falls 2.72 percent for July 29 - Eq...07/29/2021
5
Pfizers CEO Wants to Go Shopping 3 Potential Companies on Hi...08/05/2021
6
7 Biotech Stocks to Buy Amid the Delta Variants Onslaught - ...08/11/2021
7
EPS Reported08/12/2021
8
Atea gains 1.64 percent to Close at 29.21 on August 18 - Equ...08/18/2021
9
Top Covid Stocks In Play After Pfizer Vaccine Approval TOMDF...08/24/2021
10
Pfizer, Merck launch new trials of oral COVID-19 drugs - Mar...09/01/2021
11
Unclassified Event09/03/2021
12
Atea falls 6.28 percent to Close at 25.98 on September 15 - ...09/15/2021
13
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine boos...09/22/2021

About Atea Pharmaceuticals Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Atea Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2015 2016 2020 2021 (projected)
PPandE Turnover37.135.649.342.93
Long Term Debt to Equity0.0064940.0053480.006150.007743

Atea Pharmaceuticals Upcoming Company Events

As portrayed in its financial statements, the presentation of Atea Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Atea Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Atea Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Atea Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Atea Pharmaceuticals' management manipulating its earnings.
Upcoming Quarterly Report9th of December 2021
Next Earnings Report29th of March 2022
Next Fiscal Quarter End30th of September 2021
Next Fiscal Year End29th of March 2022
Last Quarter Report30th of June 2021
Last Earning Announcement30th of September 2020

Build Portfolio with Atea Pharmaceuticals

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please continue to Atea Pharmaceuticals Backtesting, Atea Pharmaceuticals Valuation, Atea Pharmaceuticals Correlation, Atea Pharmaceuticals Hype Analysis, Atea Pharmaceuticals Volatility, Atea Pharmaceuticals History and analyze Atea Pharmaceuticals Performance. Note that the Atea Pharmaceuticals information on this page should be used as a complementary analysis to other Atea Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Atea Pharmaceuticals Stock analysis

When running Atea Pharmaceuticals price analysis, check to measure Atea Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea Pharmaceuticals is operating at the current time. Most of Atea Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Atea Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atea Pharmaceuticals' price. Additionally, you may evaluate how the addition of Atea Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Atea Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Atea Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Atea Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...